B · Normal
November 4th, Novo Nordisk expects Wegovy oral medicine to be launched in more than 20 markets in 2027.
Related telegraphs
On November 4th, Novo Nordisk’s U.S. stock price rose by more than 5% before the
11-04 17:04
On November 4th, Novo Nordisk’s adjusted sales of Wegovy oral drug in the third
11-04 14:34
November 4th, Novo Nordisk expects the adjusted sales growth rate at constant ex
11-04 14:33
On October 20, Novo Nordisk said that its new generation weight loss drug CagriS
10-20 21:58
On October 7, the U.S. healthcare sector bucked the trend and rose early in the
10-07 21:52
[Nanexa and Novo Nordisk reach a 1.165 billion euro global licensing and coopera
09-25 13:33
Comments